Federal Register Notice: FDA has determined that Skelaxin (metaxalone) tablets, 400 mg was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow the agency to approve ANDAs for Skelaxin (metaxalone) tablets, 400 mg, if all other legal and regulatory requirements are met. To view this notice, click here.
